SARAH KIRKPATRICK: Open Payments
NPI 1659002764 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,359 in 62 payments from 16 companies in 2025. Trend: 2023 $2,586 · 2024 $1,787 · 2025 $5,359
Food & beverage: $2,664Consulting: $2,640Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $2,366 |
| E.R. Squibb & Sons, L.L.C. | 1 | $900 |
| Amgen Inc. | 14 | $694 |
| Novartis Pharmaceuticals Corporation | 5 | $394 |
| Janssen Scientific Affairs, LLC | 4 | $290 |
| ABBVIE INC. | 10 | $283 |
| GlaxoSmithKline, LLC. | 2 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $90 |
| Lilly USA, LLC | 1 | $67 |
| UCB, Inc. | 2 | $37 |
Products named: TREMFYA, KRYSTEXXA, COSENTYX, RINVOQ, TAVNEOS, TALTZ, OTEZLA, SKYRIZI.
Industry payments across LA — which companies pay providers there.
